v3.25.4
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance, common stock (in shares) at Jun. 30, 2024 [1]   311,053,031      
Beginning balance at Jun. 30, 2024 $ 2,731,989 $ 3 $ 5,862,555 $ (3,109,004) $ (21,565)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) [1]   432,277      
Issuance of common stock upon exercise of stock options 3,596   3,596    
Vesting of restricted stock units (in shares) [1]   2,492,095      
Vesting of warrants for common stock 107,263   107,263    
Stock-based compensation 143,711   143,711    
Tax withholding on stock-based compensation (63,208)   (63,208)    
Foreign currency translation adjustments 8,346       8,346
Unrealized gain (loss) on securities available for sale 5,589       5,589
Loss on cash flow hedges (1,492)       (1,492)
Net income (loss) (100,222)     (100,222)  
Ending balance, common stock (in shares) at Sep. 30, 2024 [1]   313,977,403      
Ending balance at Sep. 30, 2024 2,835,572 $ 3 6,053,917 (3,209,226) (9,122)
Beginning balance, common stock (in shares) at Jun. 30, 2024 [1]   311,053,031      
Beginning balance at Jun. 30, 2024 2,731,989 $ 3 5,862,555 (3,109,004) (21,565)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Foreign currency translation adjustments (27,123)        
Net income (loss) (19,862)        
Ending balance, common stock (in shares) at Dec. 31, 2024 [1]   315,735,274      
Ending balance at Dec. 31, 2024 2,785,540 $ 3 5,961,956 (3,128,866) (47,553)
Beginning balance, common stock (in shares) at Sep. 30, 2024 [1]   313,977,403      
Beginning balance at Sep. 30, 2024 2,835,572 $ 3 6,053,917 (3,209,226) (9,122)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) [1]   2,762,075      
Issuance of common stock upon exercise of stock options 30,700   30,700    
Issuance of common stock, employee share purchase plan (in shares) [1]   204,650      
Issuance of common stock, employee share purchase plan 5,092   5,092    
Repurchases of common stock (in shares) [1]   (3,526,590)      
Repurchases of common stock (250,000)   (250,000)    
Vesting of restricted stock units (in shares) [1]   2,317,736      
Vesting of warrants for common stock 86,776   86,776    
Stock-based compensation 130,806   130,806    
Tax withholding on stock-based compensation (95,335)   (95,335)    
Foreign currency translation adjustments (35,469)       (35,469)
Unrealized gain (loss) on securities available for sale (2,873)       (2,873)
Loss on cash flow hedges (89)       (89)
Net income (loss) 80,360     80,360  
Ending balance, common stock (in shares) at Dec. 31, 2024 [1]   315,735,274      
Ending balance at Dec. 31, 2024 2,785,540 $ 3 5,961,956 (3,128,866) (47,553)
Beginning balance, common stock (in shares) at Jun. 30, 2025 [1]   325,112,799      
Beginning balance at Jun. 30, 2025 3,069,009 $ 3 6,140,893 (3,056,818) (15,069)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) [1]   3,020,789      
Issuance of common stock upon exercise of stock options 94,828   94,828    
Vesting of restricted stock units (in shares) [1]   1,914,916      
Vesting of warrants for common stock 40,977   40,977    
Stock-based compensation 138,738   138,738    
Tax withholding on stock-based compensation (116,041)   (116,041)    
Foreign currency translation adjustments (10,003)       (10,003)
Unrealized gain (loss) on securities available for sale 812       812
Loss on cash flow hedges (129)       (129)
Net income (loss) 80,694     80,694  
Ending balance, common stock (in shares) at Sep. 30, 2025 [1]   330,048,504      
Ending balance at Sep. 30, 2025 3,298,885 $ 3 6,299,395 (2,976,124) (24,389)
Beginning balance, common stock (in shares) at Jun. 30, 2025 [1]   325,112,799      
Beginning balance at Jun. 30, 2025 $ 3,069,009 $ 3 6,140,893 (3,056,818) (15,069)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 1,966,068        
Foreign currency translation adjustments $ (2,167)        
Net income (loss) 210,280        
Ending balance, common stock (in shares) at Dec. 31, 2025 [1]   332,207,105      
Ending balance at Dec. 31, 2025 3,546,861 $ 3 6,410,335 (2,846,538) (16,939)
Beginning balance, common stock (in shares) at Sep. 30, 2025 [1]   330,048,504      
Beginning balance at Sep. 30, 2025 3,298,885 $ 3 6,299,395 (2,976,124) (24,389)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) [1]   276,350      
Issuance of common stock upon exercise of stock options 2,537   2,537    
Issuance of common stock, employee share purchase plan (in shares) [1]   152,596      
Issuance of common stock, employee share purchase plan 6,733   6,733    
Vesting of restricted stock units (in shares) [1]   1,729,655      
Vesting of warrants for common stock 61,206   61,206    
Stock-based compensation 124,436   124,436    
Tax withholding on stock-based compensation (83,972)   (83,972)    
Foreign currency translation adjustments 7,836       7,836
Unrealized gain (loss) on securities available for sale (81)       (81)
Loss on cash flow hedges (305)       (305)
Net income (loss) 129,586     129,586  
Ending balance, common stock (in shares) at Dec. 31, 2025 [1]   332,207,105      
Ending balance at Dec. 31, 2025 $ 3,546,861 $ 3 $ 6,410,335 $ (2,846,538) $ (16,939)
[1] The share amounts listed above combine Class A and Class B stock.